Cargando…
Vaccine platforms for the prevention of Lassa fever
Lassa fever is an acute viral haemorrhagic illness caused by Lassa virus (LASV), which is endemic throughout much of West Africa. The virus primarily circulates in the Mastomys natalensis reservoir and is transmitted to humans through contact with infectious rodents or their secretions; human-to-hum...
Autores principales: | Purushotham, Jyothi, Lambe, Teresa, Gilbert, Sarah C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier B.V. on behalf of European Federation of Immunological Societies.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7132387/ https://www.ncbi.nlm.nih.gov/pubmed/31026485 http://dx.doi.org/10.1016/j.imlet.2019.03.008 |
Ejemplares similares
-
ChAdOx1-vectored Lassa fever vaccine elicits a robust cellular and humoral immune response and protects guinea pigs against lethal Lassa virus challenge
por: Fischer, Robert J., et al.
Publicado: (2021) -
Advanced Vaccine Candidates for Lassa Fever
por: Lukashevich, Igor S.
Publicado: (2012) -
Development of a New Vaccine for the Prevention of Lassa Fever
por: Geisbert, Thomas W, et al.
Publicado: (2005) -
Pathogenesis of Lassa Fever
por: Yun, Nadezhda E., et al.
Publicado: (2012) -
PROSPECTS OF LASSA FEVER CANDIDATE VACCINES
por: Isaac, Ademusire Babatunde, et al.
Publicado: (2022)